Risk Intelligence
67 / 100
Fundamentally Qualified
How strong and defensively sound is the company?
Around the middle of the covered universe.
COR · NYSE
Sector unavailable · Industry unavailable
$321.57
+0.19%
Close on Sep 11, 2026
Updated 6/30/2026
Long-term research evidence only. No price targets, no trading signals, no recommendations.
Investment Report Card
Sector unavailable · Data confidence good
44 / 100
Rank #433 of 1,152 qualified companies
Top 63% · Not Currently Suggested
67 / 100
Fundamentally Qualified
How strong and defensively sound is the company?
Around the middle of the covered universe.
54 / 100
Weak Compounder
Does the business have the characteristics needed to create value over many years?
Weaker than most covered companies on this measure.
49 / 100
Deteriorating
Is the underlying business getting stronger or weaker?
Weaker than most covered companies on this measure.
48 / 100
Positive disclosed activity
What are important owners actually doing?
Weaker than most covered companies on this measure.
62 / 100
Attractive
Is today's price reasonable?
Around the middle of the covered universe — and valuation is researched separately from the Suggested Investment Score.
70 / 100
Strong Capital Returns
How effectively does the company reward shareholders?
Above average on this measure — and capital returns are researched separately from the Suggested Investment Score.
CENCORA INC scores 54 on Long-Term Potential (D+), described by the research model as weak compounder. This describes business characteristics only — it is not a forecast of future returns.
Disclosed ownership evidence reads 48 (D): Positive disclosed activity. 3 tracked managers disclosed a position in the latest reporting period. Ownership filings are historical disclosures, not signals.
CENCORA INC reads 62 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades above most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
CENCORA INC reads 70 out of 100 on Capital Returns Intelligence (Strong Capital Returns), reflecting a dividend that has grown about 6.4% a year and a share count falling about 1.5% a year. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
No meaningful recorded changes in the stored history.
Risk Intelligence is a core model, Long-Term Potential, Fundamental Momentum, Valuation Intelligence and Capital Returns Intelligence are research models, and Ownership Intelligence is supplemental descriptive evidence. Valuation Intelligence and Capital Returns Intelligence each contribute 0% to the Suggested Investment Score. Nothing here is a recommendation.
Compare COR with other companiesAppears in
Membership means the company satisfied a published rule on the latest research build. It is not a recommendation.
About a minute to read
Written from stored research readings only. No hype. No trading signals. Just better evidence.
CENCORA INC (COR) scores 44 out of 100 and ranks #433 of 1,152 qualified companies today. That places it in the top 63% of ranked companies. The stored tier for that score is not currently suggested.
Risk Intelligence reads 67 out of 100 (C+), recorded as fundamentally qualified. Around the middle of the covered universe.
Long-Term Potential reads 54 out of 100 (D+), recorded as weak compounder. Weaker than most covered companies on this measure.
Fundamental Momentum reads 49 out of 100 (D), recorded as deteriorating. Weaker than most covered companies on this measure.
Ownership Intelligence reads 48 out of 100 (D), recorded as positive disclosed activity. Weaker than most covered companies on this measure.
Valuation currently appears favourable: Valuation Intelligence reads 62 out of 100 (C), recorded as Attractive. CENCORA INC reads 62 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades above most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
Capital Returns Intelligence reads 70 out of 100 (B−), recorded as Strong Capital Returns. CENCORA INC reads 70 out of 100 on Capital Returns Intelligence (Strong Capital Returns), reflecting a dividend that has grown about 6.4% a year and a share count falling about 1.5% a year. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
The Fundamental Momentum research model shows deterioration. Data confidence for this company is good.
No individual layer reaches the strongest band today. Long-Term Potential and Fundamental Momentum and Ownership Intelligence remain the main area to watch. Separately from the score, valuation reads attractive at today's price.
Composite discovery model
Suggested Investment Score
44 / 100
A 0–100 composite discovery score combining Risk Intelligence, Long-Term Potential, Fundamental Momentum, and Ownership Intelligence. It helps rank qualified companies for further research and does not predict future returns.
30% contribution
30% contribution
20% contribution
20% contribution
48 / 100 · Mixed · 20% of the Suggested Investment Score
Coverage: Good
50% of Ownership Intelligence · 10% of the total score
Tracked professional-manager activity is weak.
20% of Ownership Intelligence · 4% of the total score
Broad institutional evidence from resolved filings is strong.
15% of Ownership Intelligence · 3% of the total score
No discretionary insider transactions are stored for this company, so this evidence is unavailable rather than neutral.
15% of Ownership Intelligence · 3% of the total score
No qualifying major-holder filings are stored, so this evidence is unavailable rather than neutral.
Ownership Intelligence summarizes publicly disclosed activity among professional investment managers, broader institutions, company insiders, and significant strategic owners. It adds context to investment research but is not a validated predictor of future performance. Ownership information is publicly reported with a delay; the latest applicable reporting period is 2026-06-30, publicly disclosed 9/11/2026. Congressional activity is unavailable pending legal review and contributes nothing to this reading.
No component ranks in the top quartile of the qualified universe.
Long-term potential is mid-pack
Long-Term Potential ranks below the qualified median. This remains a research model.
Fundamental Momentum is softer
Reported business trends rank below the qualified median.
Ownership evidence is not uniformly supportive
Disclosed elite investor activity evidence is weak or neutral. Ownership evidence is supplemental and never automatically positive.
Ownership evidence disagrees
Different owner groups point in different directions, so the combined reading is best read as mixed rather than uniformly favourable.
COMPOSITE DISCOVERY MODEL — RESEARCH STAGE · Data coverage Excellent. Rankings are recalculated daily using the latest available information. Individual components may update at different frequencies based on when new financial and ownership data becomes available.
Researched separately
Valuation Intelligence 62 · Attractive
Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.
Researched separately
Capital Returns Intelligence 70 · Strong Capital Returns
Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.
Score explanation
Four research areas carry fixed weights. Each area is compared against every other eligible company, then weighted. The four contributions below add to 43.8 of the stored score (43.8).
Risk Intelligence
30% of the score · contributes 17.7 points
How strong and defensively sound is the company?
Stands at the 59 percentile of eligible companies · stored reading 67 · 40% of this company’s total score
How financially sturdy the company has been when conditions turned against it.
Risk Intelligence reads stored balance-sheet strength, historical downside behaviour and the company's price-risk grouping. A stronger reading describes past resilience; it does not protect against future losses.
Full methodologyLong-Term Potential
30% of the score · contributes 14.7 points
Does the business have the characteristics needed to create value over many years?
Stands at the 49 percentile of eligible companies · stored reading 54 · 34% of this company’s total score
Whether the business has the durable characteristics long-term owners look for.
Long-Term Potential reads durability characteristics such as profitability consistency, cash generation and reinvestment capability over multiple reported periods.
Full methodologyFundamental Momentum
20% of the score · contributes 9.3 points
Is the underlying business getting stronger or weaker?
Stands at the 46 percentile of eligible companies · stored reading 49 · 21% of this company’s total score
Whether the reported business results have been getting stronger or weaker.
Fundamental Momentum compares recent reported fundamentals with the company's own earlier periods, so improvement or deterioration is measured against its history rather than against a forecast.
Full methodologyOwnership Intelligence
20% of the score · contributes 2.1 points
What are important owners actually doing?
Stands at the 11 percentile of eligible companies · stored reading 48 · 5% of this company’s total score
What large reporting owners have actually been doing with their positions.
Ownership Intelligence reads public ownership filings: how many tracked reporting owners hold the company, and whether they were adding, holding, reducing or exiting in the latest disclosed period.
Full methodologyNo research area currently stands in the stronger half of eligible companies.
Additional research — not currently included in the primary Suggested Investment Score.
Stored snapshots only
Research-score history available since September 2026.
Stored research history does not yet cover a full 30 days comparison for this company.
A change is reported as meaningful at 8 score points, 5 rank places, or any change of research classification. Nothing here is a recommendation to buy or sell.
Plain-English definitions, with the formula and the limitations of each measure.
Fifth research lens · outside the score
Valuation Intelligence
Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.
Attractive
29
Expensive
Is this company expensive or inexpensive compared with its own history?
68
Attractive
How expensive is this stock compared with similar companies?
64
Attractive
How much financial output does an investor receive relative to the price paid?
99
Very Attractive
Does the company's growth help justify the valuation investors are paying?
CENCORA INC reads 62 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades above most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.
Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026
Stored readings only. The dashed line is this company's own median for the selected measure.
Only one stored valuation reading exists so far, so there is nothing to chart yet. Valuation history builds forward from activation rather than being reconstructed.
Current P/E 23.4x · own median 20.5x · peer median 25.1x
Valuation is inherently uncertain. A stock that appears inexpensive can continue falling, and a stock that appears expensive can continue rising. Valuation Intelligence provides context about the price investors are paying — it does not predict short-term market movements, and it never produces a fair value, a price target or a buy or sell range. Model VALUATION_INTELLIGENCE_V1.
Sixth research lens · outside the score
Capital Returns Intelligence
Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.
Strong Capital Returns
89
Exceptional Capital Returns
Dividend reliability
51
Moderate Capital Returns
Do buybacks actually reduce shares?
62
Favorable Capital Returns
Is your ownership share protected?
88
Exceptional Capital Returns
Can the cash flow support it?
52
Moderate Capital Returns
Cash returned versus company value
CENCORA INC reads 70 out of 100 on Capital Returns Intelligence (Strong Capital Returns), reflecting a dividend that has grown about 6.4% a year and a share count falling about 1.5% a year.
How returned cash was used
Dividends $468.07M · net repurchases $993.53M · total returned $1.46B · 36% of free cash flow
Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026
Stored readings only. History builds forward from activation rather than being reconstructed.
Only one stored reading exists for this measure so far, so there is nothing to chart yet.
A very high dividend yield may reflect a falling share price or an unsustainable payout. Capital Returns Intelligence emphasizes consistency and sustainability rather than simply rewarding the highest yield.
Announced or gross buyback spending does not always mean shareholders are gaining ownership. Companies can simultaneously issue shares through employee compensation or acquisitions. Suggested Investments therefore considers actual share-count changes alongside repurchase spending.
Capital Returns Intelligence describes how a company returns capital to shareholders. It is not a measure of stock-price performance, it does not predict future returns, and a strong reading is never a recommendation to buy. Dividends and repurchases can be reduced or stopped at any time. Model CAPITAL_RETURNS_INTELLIGENCE_V1, contributing 0% to the Suggested Investment Score.
Stored daily snapshots only
| Today | #433 | Score 44 |
|---|---|---|
| 30 days ago | Not ranked | No stored score |
| 90 days ago | Not ranked | No stored score |
| First suggested | Not yet suggested | |
| Highest rank | #433 | |
In the company’s own words
As used herein, the terms "Company," "Cencora," "we," "us," or "our" refer to Cencora, Inc., a Delaware corporation.
Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. We deliver innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health. More specifically, we distribute a comprehensive offering of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers located in the United States and select global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other customers. Additionally, we furnish healthcare providers and pharmaceutical manufacturers with an assortment of related services, including data analytics, outcomes research, reimbursement and pharmaceutical consulting services (including regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance) niche premium logistics services, inventory management, pharmacy automation, pharmacy management, and packaging solutions.
References to "fiscal 2025," "fiscal 2024," and "fiscal 2023" refer to the fiscal years ended September 30, 2025, 2024, and 2023, respectively.
Pharmaceutical sales in the United States, as recently estimated by IQVIA, an independent third-party provider of information to the pharmaceutical and healthcare industry, are expected to grow at a compound annual growth rate of approximat e ly 8.4% f rom 2024 through 2029, an d the growth rate is dependent, in part, on pharmaceutical manufacturer price increases. In addition to general economic conditions, factors that impact the growth of the pharmaceutical industry in the U.S. and other industry trends include:
Quoted from the business section of this company’s 10-K filed November 25, 2025. Read the filing
Four distinct intelligence areas
67
Fundamentally Qualified
+6.1 vs Jun 30, 2026
Business Quality qualification score from the locked IA Defensive Research Core. Price Risk stays a separate category and is never blended in.
As of Sep 11, 2026
54
Ordinary Compounder
+17.5 vs Jun 30, 2026
Durable business economics and reinvestment characteristics. Independent external validation is pending.
As of Sep 11, 2026
49
Middle
+10.3 vs Jun 30, 2026
Direction and breadth of change in underlying business fundamentals. Not a price-momentum signal.
As of Sep 11, 2026
33
Lower range
0 vs Jun 30, 2026
Only 3 tracked managers disclosed a position — treat as limited coverage.
As of Sep 11, 2026
Company intelligence
Each area is measured and reported separately. No combined score exists.
COR intelligence history from 2023-09-30 to 2026-09-11. Risk Intelligence 66.7 on 2026-09-11, up 6.1 from 60.6 on 2026-06-30. Long-Term Potential 54 on 2026-09-11, up 17.5 from 36.5 on 2026-06-30. Fundamental Momentum 49.2 on 2026-09-11, up 10.3 from 38.9 on 2026-06-30. Elite Investor Activity 33.3 on 2026-09-11, unchanged 0 from 33.3 on 2026-06-30. Each area is reported separately and is never combined into a single score.
Risk Intelligence 66.7 as of Sep 11, 2026 (+6.1 vs prior period) · Production core
Long-Term Potential 54 as of Sep 11, 2026 (+17.5 vs prior period) · Research model
Fundamental Momentum 49.2 as of Sep 11, 2026 (+10.3 vs prior period) · Research model
Elite Investor Activity 33.3 as of Sep 11, 2026 (0 vs prior period) · Supplemental
Share price
Closing prices adjusted for splits and dividends, through Sep 11, 2026. Past prices do not indicate future results.
Last stored close $321.57 · +7.0% over the selected range · 52 sessions shown
Balanced evidence
Risk and uncertainty
Public filings · descriptive only
Reporting holders
1
New holders
1
Increasing
0
Reducing
0
Exiting
0
Coverage
Excellent
Positive disclosed activity · Report period 2016-12-31 · Public 12/22/2023
| Manager | Change | Portfolio weight | Rank | Disclosed |
|---|
Insufficient high-confidence manager coverage.
Objective stored changes
Price Risk category changed
Price Risk moved from Not Available to Normal risk.
IA Compounder strengthened
IA Compounder research score moved from 36.5 to 47.5.
Fundamental Momentum improved
Fundamental Momentum research score moved from 38.9 to 45.3.
Tracked managers exited positions
2 tracked managers no longer disclosed a position for the reporting period ending 2026-09-11.
IA Compounder softened
IA Compounder research score moved from 47.8 to 36.5.
Elite Investor Consensus weakened
Disclosed agreement among tracked managers moved from 83 to 33 for the reporting period ending 2026-06-30.
Tracked managers exited positions
2 tracked managers no longer disclosed a position for the reporting period ending 2026-06-30.
Elite Investor Consensus strengthened
Disclosed agreement among tracked managers moved from 67 to 83 for the reporting period ending 2026-03-31.
Elite Investor Consensus strengthened
Disclosed agreement among tracked managers moved from 50 to 63 for the reporting period ending 2025-09-30.
Elite Investor Consensus weakened
Disclosed agreement among tracked managers moved from 67 to 50 for the reporting period ending 2025-06-30.
No high-confidence public ownership events are available.
General research only. Not personalized advice. Public filings may be delayed, amended, incomplete, or reflect positions that have changed since the reporting date.